Pangea Biomed
Pangea Biomed
Biotech company using AI and deep RNA analysis to predict cancer treatment response.
About
Technology stack
detected 2026-06-29No comments yet. Be the first to share your take.
What does Pangea Biomed do?
Pangea Biomed is redefining precision oncology by combining molecular biology with bioinformatics and machine learning. Their proprietary tumor intelligence platform, ENLIGHT, analyzes gene expression, epigenetics, and proteomics to uncover tumor vulnerabilities and predict patient response to therapy, going beyond genomic abnormalities. Pangea serves the oncology field by accelerating drug discovery, enabling personalized treatment nominations, and improving clinical efficiency.
How much funding has Pangea Biomed raised?
Pangea Biomed has raised a total of $12M in funding. The most recent round on record is Seed.
Where is Pangea Biomed headquartered?
Pangea Biomed is headquartered in Tel Aviv, Israel.
When was Pangea Biomed founded?
Pangea Biomed was founded in 2019.
What industry does Pangea Biomed operate in?
Pangea Biomed operates in Healthcare, Oncology, Genomics, Biotech, HealthTech, Drug Discovery.
How many employees does Pangea Biomed have?
Pangea Biomed has approximately 16 people on record.